Cargando…
Fibroblast growth factor 23 and 25-hydroxyvitamin D levels are associated with estimated glomerular filtration rate decline
The combination of serum 25-hydroxyvitamin D (25D) and fibroblast growth factor 23 (FGF23) levels predict hard renal outcomes in patients with chronic kidney disease (CKD), independent of classical markers of mineral and bone disorders, including serum phosphorus, parathyroid hormone, 1,25-dihydroxy...
Autores principales: | Hamano, Takayuki, Nakano, Chikako, Obi, Yoshitsugu, Fujii, Naohiko, Matsui, Isao, Tomida, Kodo, Mikami, Satoshi, Inoue, Kazunori, Shimomura, Akihiro, Kusunoki, Yasuo, Rakugi, Hiromi, Isaka, Yoshitaka, Tsubakihara, Yoshiharu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4089736/ https://www.ncbi.nlm.nih.gov/pubmed/25019032 http://dx.doi.org/10.1038/kisup.2013.97 |
Ejemplares similares
-
Serum phosphate levels modify the impact of parathyroid hormone levels on renal outcomes in kidney transplant recipients
por: Doi, Yohei, et al.
Publicado: (2020) -
Effect of cholecalciferol on serum hepcidin and parameters of anaemia and CKD-MBD among haemodialysis patients: a randomized clinical trial
por: Obi, Yoshitsugu, et al.
Publicado: (2020) -
Magnesium Modifies the Cardiovascular Mortality Risk Associated with Hyperphosphatemia in Patients Undergoing Hemodialysis: A Cohort Study
por: Sakaguchi, Yusuke, et al.
Publicado: (2014) -
Massive and rapid left ventricular calcification
por: Iwatani, Hirotsugu, et al.
Publicado: (2009) -
Association between Density of Coronary Artery Calcification and Serum Magnesium Levels among Patients with Chronic Kidney Disease
por: Sakaguchi, Yusuke, et al.
Publicado: (2016)